Heart and vascular medicine
Trial results, device approvals and practice guidance across cardiology, interventional care and vascular medicine.
Cardiology
ITACS addresses IV iron before cardiac surgery, but the supplied citation lacks the numerical results needed to determine whether it reduces transfusion or improves recovery.
Rayan Salih · September 24, 2026 · 6 min
Cardiology
Across 35 randomized trials, high-dose omega-3 treatment was associated with higher atrial fibrillation risk. The absolute increase was modest but relevant for cardiovascular patients.
Rayan Salih · 6 min read
Cardiology
Across randomized heart-failure trials, SGLT2 inhibitors most reliably reduce worsening heart failure and cardiovascular death. Evidence for lower all-cause mortality is less secure.
Rayan Salih · 7 min read
Cardiology
A 2026 meta-analysis found that digitalis glycosides reduced worsening heart failure events, but not cardiovascular death, reinforcing a selective rather than routine role.
Dr. Abu Bakar · 7 min read
Cardiology
FDA approval adds baxdrostat as an aldosterone-targeted option for adults whose hypertension remains uncontrolled on combination therapy.
Rayan Salih · 7 min read
Cardiology
A 2026 meta-analysis estimated 32% lower odds of major cardiovascular events with semaglutide. The result supports cardiovascular benefit discussions but requires context on heterogeneity, absolute risk and indication.
Dr. Abu Bakar · 6 min read
Cardiology
In a randomized trial, acoramidis preserved patient-reported health status and reduced cardiovascular hospitalizations over 30 months in adults with transthyretin amyloid cardiomyopathy.
Rayan Salih · 7 min read
Cardiology
A randomized trial reported that stopping primary-prevention statins in adults 75 or older was noninferior to continuation for 3-year mortality. The confidence interval is central to applying that result.
Rayan Salih · 6 min read
Cardiology
FINEARTS-HF found that baseline blood pressure did not materially alter finerenone’s effect on cardiovascular death and total worsening heart failure events in patients with LVEF of 40% or higher.
Rayan Salih · 6 min read
Cardiology
A randomized-trial meta-analysis found less major bleeding with 3–6 months of DAPT after PCI than with 12 months, while major cardiovascular events were not significantly increased.
Rayan Salih · 6 min read
Cardiology
The 2026 CKM guideline calls for earlier, integrated prevention when cardiovascular, kidney and metabolic risks coexist, with action spanning primary care, endocrinology, nephrology and cardiology.
Dr. Abu Bakar · 7 min read
Cardiology
TRACK found no cardiovascular benefit and more major bleeding when low-dose rivaroxaban was added in stage 4–5 CKD or dialysis-dependent kidney failure.
Rayan Salih · 6 min read
Cardiology
The 2026 multisociety guideline defines a unified pathway for evaluating cardiovascular, kidney and metabolic risk, particularly when disease or risk factors overlap.
Rayan Salih · 7 min read
Cardiology
The DAPT-MVD citation alone does not provide enough verified numerical detail to weigh another year of clopidogrel plus aspirin after multivessel PCI.
Rayan Salih · 6 min read
Cardiology
The 2026 guideline retains a 130/80 mm Hg diagnostic threshold but links medication timing to cardiovascular, diabetes and kidney risk. Most treated adults share a target below 130/80 mm Hg.
Rayan Salih · 7 min read
Cardiology
The 2026 consensus sharpens how heart failure should be identified and documented when symptoms, cardiac abnormalities, biomarkers and evidence of congestion disagree.
Rayan Salih · 7 min read
Cardiology
FDA approval makes enlicitide the first oral PCSK9 inhibitor for adults who need additional LDL-C lowering despite maximally tolerated statins, including those with heterozygous familial hypercholesterolemia.
Rayan Salih · 6 min read
Cardiology
OPTIMA-AF supports stopping the P2Y12 inhibitor after 1 month in selected patients with atrial fibrillation undergoing PCI, reducing important bleeding without an apparent loss of thromboembolic protection.
Egbavwe Pela · 6 min read
Cardiology
Aortic regurgitation is a common heart valve problem where the aortic valve doesn’t close tightly.
Dr. Abu Bakar · 6 min read
Cardiology
Cardio-oncology is an emerging field that brings cardiologists and oncologists together to prevent and treat heart and vascular problems
Dr. Abu Bakar · 7 min read
Cardiology
Monoclonal antibodies that target the PCSK-9 protein are now part of routine discussions about managing high cholesterol (hyperlipidemia).
Dr. Abu Bakar · 8 min read
Cardiology
Once rare, infective endocarditis from injecting drugs is now a leading cause of heart valve surgery in many
Dr. Abu Bakar · 6 min read
Cardiology
For decades, low-density lipoprotein cholesterol (LDL-C) management has served as the bedrock of primary and secondary cardiovascular disease
Rayan Salih · 8 min read
Cardiology
Precision medicine is revolutionizing the field of cardiovascular medicine, and CYP2C19 genotyping has emerged as one of the
Dr. Abu Bakar · 9 min read
Cardiology
Nyra Medical has enrolled the first patient in the ENHANCE early feasibility study of its investigational CARLEN transcatheter
Dr. Abu Bakar · 9 min read
Cardiology
Aortic stenosis (AS) is a common heart valve problem in older adults, and clinicians often judge its severity by
Dr. Abu Bakar · 7 min read
Cardiology
Mayo Clinic Florida is the first center to use the Impella 5.
Dr. Abu Bakar · 7 min read
Cardiology
Vascular rings are rare birth defects of the aortic arch that form a loop around a baby’s windpipe
Dr. Abu Bakar · 9 min read
Cardiology
Highly sensitized pediatric heart patients face one of the greatest challenges in heart transplantation.
Dr. Abu Bakar · 8 min read
Cardiology
For children with obstructive hypertrophic cardiomyopathy (HCM), doctors now view septal myectomy not just as a last resort,
Dr. Abu Bakar · 8 min read
Cardiology
Cardiovascular disease (CVD) in pregnancy presents unique challenges that demand coordinated care across specialties.
Dr. Abu Bakar · 7 min read
Cardiology
Social determinants of health (SDOH) are the primary drivers of widespread disparities across the continuum of acute cerebrovascular
Rayan Salih · 7 min read
Cardiology
Sudden cardiac death happens when the heart stops beating without warning, often in people who seemed healthy.
Dr. Abu Bakar · 7 min read
Cardiology
Prescribing a first-line antihypertensive medication is one of the most frequent clinical decisions made in primary care and
Rayan Salih · 8 min read
Cardiology
Tricuspid regurgitation (TR) is a heart valve problem that is often underestimated, but it can seriously affect a
Dr. Abu Bakar · 10 min read
Cardiology
A recent transplant at an Arizona medical center became the state’s first to use a cutting edge “heart-in-a-box”
Dr. Abu Bakar · 7 min read
Cardiology
As our clinical landscape shifts toward managing increasingly multi-morbid aging populations, the intersection of cardiovascular health and neurodegenerative
Rayan Salih · 8 min read
Cardiology
Reflow Medical is pitching a different take on the coronary drug-eluting stent: a temporary, retrievable scaffold that delivers
Dr. Abu Bakar · 9 min read
Cardiology
Left ventricular systolic dysfunction is the heart problem behind many cases of heart failure, and it often develops
Dr. Abu Bakar · 7 min read
Cardiology
For decades, acute ischemic stroke management has been governed by a singular, unyielding paradigm: “Time is brain.
Rayan Salih · 10 min read
One story a day
One health journey each morning — no advice, no alarm, just company for the road.
